| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort.
|
J Am Geriatr Soc
|
2011
|
2.38
|
|
2
|
Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
|
Am J Respir Crit Care Med
|
2007
|
2.18
|
|
3
|
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
|
Crit Care
|
2010
|
2.11
|
|
4
|
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.
|
Pharmacogenetics
|
2004
|
2.06
|
|
5
|
The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: guide to the Register, version 3-2010.
|
Clin Chem Lab Med
|
2010
|
1.68
|
|
6
|
The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations.
|
Nephrol Dial Transplant
|
2009
|
1.43
|
|
7
|
Prolonged unconsciousness in a patient on automated peritoneal dialysis.
|
Eur J Emerg Med
|
2006
|
1.38
|
|
8
|
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients.
|
Pharmacogenomics
|
2011
|
1.27
|
|
9
|
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock.
|
Crit Care
|
2010
|
1.26
|
|
10
|
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids.
|
Transplantation
|
2005
|
1.21
|
|
11
|
Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.
|
Respir Res
|
2006
|
1.12
|
|
12
|
Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: importance of optimal scheduling to exploit the 'normalization' window of the tumor vasculature.
|
Cancer Lett
|
2006
|
1.11
|
|
13
|
Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.
|
Am J Respir Cell Mol Biol
|
2009
|
1.11
|
|
14
|
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.
|
Thromb Haemost
|
2013
|
1.02
|
|
15
|
The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium.
|
BMC Geriatr
|
2010
|
1.01
|
|
16
|
Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
|
Forensic Sci Int
|
2005
|
1.01
|
|
17
|
Basic protocol for transepithelial nasal potential difference measurements.
|
J Cyst Fibros
|
2004
|
1.01
|
|
18
|
The EC4 European syllabus for post-graduate training in clinical chemistry and laboratory medicine: version 4--2012.
|
Clin Chem Lab Med
|
2012
|
0.99
|
|
19
|
Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients.
|
Pharmacogenomics
|
2010
|
0.95
|
|
20
|
Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
|
Clin Pharmacokinet
|
2009
|
0.94
|
|
21
|
A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
|
J Clin Pharmacol
|
2011
|
0.93
|
|
22
|
Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.
|
Antimicrob Agents Chemother
|
2003
|
0.93
|
|
23
|
An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
|
Clin Biochem
|
2007
|
0.93
|
|
24
|
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation.
|
Pharmacogenet Genomics
|
2007
|
0.92
|
|
25
|
Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
|
Ther Drug Monit
|
2009
|
0.91
|
|
26
|
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation.
|
Pharmacogenomics
|
2010
|
0.90
|
|
27
|
Iodine and iron status of pregnant women in Lubumbashi, Democratic Republic of Congo.
|
Public Health Nutr
|
2013
|
0.90
|
|
28
|
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
|
Thromb Res
|
2002
|
0.90
|
|
29
|
Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.
|
Int J Antimicrob Agents
|
2011
|
0.89
|
|
30
|
Glycosomal ABC transporters of Trypanosoma brucei: characterisation of their expression, topology and substrate specificity.
|
Int J Parasitol
|
2010
|
0.89
|
|
31
|
The glomerular filtration rate estimated by new and old equations as a predictor of important outcomes in elderly patients.
|
BMC Med
|
2014
|
0.88
|
|
32
|
The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC).
|
Clin Chem Lab Med
|
2009
|
0.88
|
|
33
|
Significance of serum immune markers in identification of global functional impairment in the oldest old: cross-sectional results from the BELFRAIL study.
|
Age (Dordr)
|
2013
|
0.87
|
|
34
|
Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.
|
Ther Drug Monit
|
2013
|
0.87
|
|
35
|
The prevalence of cardiac dysfunction and the correlation with poor functioning among the very elderly.
|
Int J Cardiol
|
2011
|
0.87
|
|
36
|
Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring?
|
Clin Chem
|
2012
|
0.87
|
|
37
|
Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study.
|
Transpl Int
|
2011
|
0.87
|
|
38
|
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation.
|
Ther Drug Monit
|
2016
|
0.86
|
|
39
|
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice.
|
J Cyst Fibros
|
2012
|
0.86
|
|
40
|
Monitoring of urea and potassium by reverse iontophoresis in vitro.
|
Pharm Res
|
2007
|
0.85
|
|
41
|
Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis.
|
PLoS One
|
2013
|
0.85
|
|
42
|
Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetes.
|
Diabetes Care
|
2003
|
0.85
|
|
43
|
Automated serum protein electrophoresis by Capillarys.
|
Clin Chem Lab Med
|
2003
|
0.84
|
|
44
|
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function.
|
Clin Chem Lab Med
|
2006
|
0.84
|
|
45
|
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice.
|
J Cyst Fibros
|
2009
|
0.84
|
|
46
|
Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy.
|
Ther Drug Monit
|
2012
|
0.84
|
|
47
|
Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.
|
Am J Respir Crit Care Med
|
2009
|
0.84
|
|
48
|
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
|
Pharmacogenomics
|
2014
|
0.83
|
|
49
|
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
|
Transplantation
|
2008
|
0.83
|
|
50
|
Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid.
|
J Nutr
|
2009
|
0.82
|
|
51
|
Mass spectrometry in laboratory medicine: When "high-tech" meets routine needs.
|
Clin Biochem
|
2010
|
0.82
|
|
52
|
Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.
|
J Anal Toxicol
|
2007
|
0.82
|
|
53
|
Cocaine induces a mixed lysosomal lipidosis in cultured fibroblasts, by inactivation of acid sphingomyelinase and inhibition of phospholipase A1.
|
Toxicol Appl Pharmacol
|
2004
|
0.81
|
|
54
|
Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.
|
Clin Chem
|
2007
|
0.81
|
|
55
|
Evaluation of a new Sebia kit for analysis of hemoglobin fractions and variants on the Capillarys system.
|
Clin Chem Lab Med
|
2006
|
0.81
|
|
56
|
Airway ion transport impacts on disease presentation and severity in cystic fibrosis.
|
Clin Biochem
|
2008
|
0.81
|
|
57
|
Permeability of gloves to selected chemotherapeutic agents after treatment with alcohol or isopropyl alcohol.
|
Am J Health Syst Pharm
|
2012
|
0.81
|
|
58
|
Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
|
Nephrol Dial Transplant
|
2005
|
0.81
|
|
59
|
Stearoyl-CoA desaturase is an essential enzyme for the parasitic protist Trypanosoma brucei.
|
Biochem Biophys Res Commun
|
2011
|
0.81
|
|
60
|
Genetic and chemical evaluation of Trypanosoma brucei oleate desaturase as a candidate drug target.
|
PLoS One
|
2010
|
0.80
|
|
61
|
Fomepizole alone for severe infant ethylene glycol poisoning.
|
Pediatr Crit Care Med
|
2004
|
0.80
|
|
62
|
The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old.
|
Arch Gerontol Geriatr
|
2012
|
0.80
|
|
63
|
Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study.
|
Ann Surg
|
2008
|
0.79
|
|
64
|
High prevalence of thyroid dysfunction among pregnant women in Lubumbashi, Democratic Republic of Congo.
|
Thyroid
|
2013
|
0.79
|
|
65
|
Interleukin-6 predicts short-term global functional decline in the oldest old: results from the BELFRAIL study.
|
Age (Dordr)
|
2014
|
0.79
|
|
66
|
A fast ultra-performance liquid chromatography method for simultaneous quantification of mycophenolic acid and its phenol- and acyl-glucuronides in human plasma.
|
Ther Drug Monit
|
2009
|
0.79
|
|
67
|
Modified method to measure nasal potential difference.
|
Clin Chem Lab Med
|
2003
|
0.79
|
|
68
|
Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients.
|
Pharmacogenomics
|
2009
|
0.79
|
|
69
|
Electrocardiographic changes with segmental akinesia after chloral hydrate overdose.
|
J Emerg Med
|
2006
|
0.79
|
|
70
|
Therapeutic Drug Monitoring of Everolimus: A Consensus Report.
|
Ther Drug Monit
|
2016
|
0.79
|
|
71
|
Long-term medical complications and quality of life in adult recipients surviving 10 years or more after liver transplantation.
|
Acta Gastroenterol Belg
|
2005
|
0.78
|
|
72
|
Drug prescriptions unadapted to the renal function in patients aged 80 years and older.
|
Eur J Gen Pract
|
2013
|
0.78
|
|
73
|
Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.
|
Clin Pharmacokinet
|
2007
|
0.78
|
|
74
|
Alfentanil-induced miosis clearance as a liver CYP3A4 and 3A5 activity measure in healthy volunteers: improvement of experimental conditions.
|
J Clin Pharmacol
|
2005
|
0.78
|
|
75
|
Value of adding natriuretic peptides and electrocardiographic findings to assess the presence of cardiac dysfunction in patients ≥80 years of age.
|
Am J Cardiol
|
2013
|
0.78
|
|
76
|
Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?
|
Clin Pharmacokinet
|
2002
|
0.78
|
|
77
|
Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs.
|
Ther Drug Monit
|
2016
|
0.77
|
|
78
|
Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive Drugs.
|
Ther Drug Monit
|
2015
|
0.77
|
|
79
|
Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
|
Clin Chem
|
2008
|
0.77
|
|
80
|
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
|
Clin Biochem
|
2012
|
0.77
|
|
81
|
Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipients.
|
Pediatr Transplant
|
2002
|
0.77
|
|
82
|
Life-threatening dextromethorphan intoxication associated with interaction with amitriptyline in a poor CYP2D6 metabolizer: a single case re-exposure study.
|
J Pain Symptom Manage
|
2008
|
0.77
|
|
83
|
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen.
|
Pharmacogenomics
|
2015
|
0.77
|
|
84
|
Estimating GFR in the oldest old: does it matter what equation we use?
|
Age Ageing
|
2011
|
0.77
|
|
85
|
Prevalence of microalbuminuria and diagnostic value of dipstick proteinuria in outpatients from HIV clinics in Bukavu, the Democratic Republic of Congo.
|
BMC Nephrol
|
2014
|
0.77
|
|
86
|
Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles.
|
J Cyst Fibros
|
2012
|
0.76
|
|
87
|
Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.
|
Toxicol Lett
|
2005
|
0.76
|
|
88
|
HPLC-high resolution mass spectrometry in clinical laboratory?
|
Clin Biochem
|
2010
|
0.76
|
|
89
|
Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation.
|
Ther Drug Monit
|
2015
|
0.75
|
|
90
|
Enteric hyperoxaluria in chronic pancreatitis.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
91
|
Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study.
|
Eur J Clin Invest
|
2013
|
0.75
|
|
92
|
Multicenter analytical evaluation of the automated electrochemiluminescence immunoassay for cyclosporine.
|
Ther Drug Monit
|
2014
|
0.75
|
|
93
|
Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation.
|
Br J Clin Pharmacol
|
2013
|
0.75
|
|
94
|
Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.
|
Ther Drug Monit
|
2014
|
0.75
|
|
95
|
Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee.
|
Ther Drug Monit
|
2016
|
0.75
|
|
96
|
Individually tailored immunosuppression: is there a role for biomarkers?
|
Clin Chem
|
2011
|
0.75
|
|
97
|
Effervescent paracetamol poisoning: a case report.
|
Eur J Emerg Med
|
2002
|
0.75
|
|
98
|
Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry.
|
Clin Biochem
|
2013
|
0.75
|
|
99
|
Prolonged hypotension due to deliberate trazodone overdose in the presence of fluoxetine.
|
Ann Clin Psychiatry
|
2007
|
0.75
|
|
100
|
Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
|
Clin Biochem
|
2013
|
0.75
|
|
101
|
Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!
|
Transpl Int
|
2010
|
0.75
|
|
102
|
Toxicokinetics of cocaine and metabolites in a body-packer becoming symptomatic.
|
J Forensic Leg Med
|
2011
|
0.75
|
|
103
|
Clinically unexpected cyclosporine levels using the ACMIA method on the RXL dimension analyser.
|
Nephrol Dial Transplant
|
2011
|
0.75
|
|
104
|
The ABCs of clinical biochemistry.
|
Clin Biochem
|
2011
|
0.75
|